Phoenix Life Sciences Terminates Merger with MediJane Holdings
(firmenpresse) - DENVER, CO -- (Marketwired) -- 01/10/17 -- Phoenix Life Sciences Inc., a disruptive healthcare solutions company, hereby announces that it is terminating its merger with MediJane Holdings, Inc. (OTCQB: MJMD).
Phoenix Life Sciences is a disruptive healthcare solutions company.
Our business is to research, produce, and distribute products around the globe that target and treat the following seven major categories of medical conditions: pain, cancer, psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. These categories include conditions that effect hundreds of millions of patients worldwide. Phoenix Life Sciences is building an integrated healthcare organization by creating products and programs using emerging biological products such as cannabinoids and other plant extracts. Delivering these programs through managed agriculture, pharmaceutical production and physician education and distribution networks.
Phoenix Life Sciences, Inc.
Investor Relations
Phone: 720-575-6255
E-mail:
For more information, visit
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.01.2017 - 21:59 Uhr
Sprache: Deutsch
News-ID 516844
Anzahl Zeichen: 0
contact information:
Town:
DENVER, CO
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 303 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Phoenix Life Sciences Terminates Merger with MediJane Holdings"
steht unter der journalistisch-redaktionellen Verantwortung von
Phoenix Life Sciences Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
